Ingenious Targeting Laboratory
PrivateLast Round
Grant
Jun 9, 2022
Total Funding Raised
$1.36M
Company Overview
Ingenious Targeting Laboratory is a biotechnology company that provides custom genetically engineered mouse, rat, and rabbit models for biomedical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ingenious Targeting Laboratory Comparables
Compare Ingenious Targeting Laboratory with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ozgene | 91% | |
| Mirimus Inc. | 89% | |
| Genoway | 87% |
Ingenious Targeting Laboratory Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2022 | ||||
| Grant | Jan 4, 2021 | ||||
| Debt | May 1, 2020 | ||||
| Grant | Feb 11, 2019 |
Ingenious Targeting Laboratory Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Long Island High Technology Incubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 40% MoM.
- Jan 21, 2026
Monthly visitors increased 55% MoM, reaching 3.5K.
Ingenious Targeting Laboratory Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ingenious Targeting Laboratory's valuation, stock price, and market status.
Is Ingenious Targeting Laboratory a public or private company?
Ingenious Targeting Laboratory is a private company.
What is the current stock price of Ingenious Targeting Laboratory?
Ingenious Targeting Laboratory is a private company with no public stock price. Caplight tracks Ingenious Targeting Laboratory's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Ingenious Targeting Laboratory worth (valuation)?
Valuation information for Ingenious Targeting Laboratory is not publicly available.
Can I buy Ingenious Targeting Laboratory stock?
Ingenious Targeting Laboratory shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ingenious Targeting Laboratory's last funding round?
Ingenious Targeting Laboratory's most recent funding round was Grant on June 9, 2022.
Who are the main investors in Ingenious Targeting Laboratory?
Key investors in Ingenious Targeting Laboratory include National Institute of Allergy and Infectious Diseases, NIH RADx, Long Island High Technology Incubator.
Will Ingenious Targeting Laboratory IPO soon?
No public IPO plans have been announced for Ingenious Targeting Laboratory.
How can I track Ingenious Targeting Laboratory secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ingenious Targeting Laboratory's secondary market activity and sign up for updates.